According to the official website of the State Food and drug administration, on November 22, the State Food and Drug Administration held a promotion meeting on Comprehensively Strengthening the construction of drug supervision capacity, deeply studied and implemented the requirements of the 18th meeting of the Central Commission for comprehensively deepening reform and the implementation opinions of the general office of the State Council on Comprehensively Strengthening the construction of drug supervision capacity (hereinafter referred to as the Implementation Opinions), summarized and exchanged local experiences, We will make greater efforts to strengthen the capacity-building of drug supervision throughout the system. Xu Jinghe, member of the Party group and deputy director of the State Food and drug administration, stressed the need to strengthen overall coordination, pay close attention to the establishment and effective operation of the drug safety coordination mechanism, and promote the solution of major problems in drug safety work. In May this year, the general office of the State Council issued the implementation opinions, which pointed out that drug safety is related to people's health and life safety. With the deepening of the reform, the shortcomings of the drug regulatory system and regulatory capacity have become increasingly prominent, affecting the people's sense of access to the drug regulatory reform. According to the implementation opinions, accelerate the establishment and improvement of a scientific, efficient and authoritative drug supervision system, firmly hold the bottom line of drug safety, further improve the scientific, legalized, international and modern level of drug supervision, promote China's leap from a large pharmaceutical country to a powerful pharmaceutical country, and better meet the people's needs for drug safety. The meeting stressed the need to comprehensively and accurately grasp the major task of strengthening the capacity-building of drug supervision, strengthen confidence, do solid work, continue to promote, take credit for a long time, and accelerate the construction of drug supervision capacity to a new level. We should accurately understand the distinctive characteristics of the implementation opinions, comprehensively grasp the overall requirements, key tasks and safeguard measures put forward in the implementation opinions, carefully sort out, pay close attention to the implementation, connect up and down, and promote overall progress. We should highlight the focus of work, earnestly strengthen the organization and leadership, improve the quality of the supervision team, improve the inspection and law enforcement system, improve the inspection and case handling mechanism, and strengthen the coordination of the supervision departments. Xu Jinghe stressed that the construction of regulatory capacity is a basic, overall and strategic work related to the long-term development of drug regulatory undertakings. Drug regulatory departments at all levels shall regard the implementation of the implementation opinions as the "top project", and the main responsible persons shall personally study and deploy, coordinate and promote and supervise the implementation. We should closely integrate the central decision-making and deployment with the actual situation of the region and the unit in accordance with the idea of making up for weaknesses, strengthening strengths and weaknesses, consolidating the foundation and promoting strengths. We should pay close attention to the division of tasks, clarify the target and time limit, establish a work account, strengthen supervision and supervision, and ensure the completion of tasks on schedule. We should give play to the role of assessment baton and study and set up drug safety assessment indicators according to the actual situation of regulatory capacity-building. We should adhere to the construction of regulatory capacity and the drug safety plan of the 14th five year plan with deployment, implementation and inspection. (outlook new era)